Literature DB >> 15572496

Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.

Ilkka Rauramo1, Iina Elo, Olav Istre.   

Abstract

OBJECTIVE: The purpose of this study was to compare the long-term efficacy of the levonorgestrel intrauterine system and transcervical resection of the endometrium in the treatment of menorrhagia.
METHODS: This study was an open, randomized 3-year trial. Patients with menorrhagia were assigned randomly to either the levonorgestrel intrauterine system (n = 30) or endometrial resection (n = 29). Pictorial blood loss assessment charts were used to measure menstrual blood loss. A pictorial blood-loss assessment chart score exceeding 75 (representing menstrual blood loss >/=60 mL) was used to diagnosis the patient as having menorrhagia. Discontinuations and cases requiring repeat operations were evaluated.
RESULTS: Pictorial blood loss scores decreased from a baseline median of 261.5 (range, 60-1503) to 7 (range, 0-101; P < .001) for the levonorgestrel intrauterine system and from 311 (range, 81-2506) to 4 (range, 0-182; P < .001) for transcervical resection of the endometrium. Nineteen women of 30 using the levonorgestrel intrauterine system completed the 3-year follow-up compared with 22 of 29 for transcervical resection of the endometrium.
CONCLUSION: Both treatments efficiently reduced menstrual bleeding. The high continuation rate suggests that the levonorgestrel intrauterine system is comparable with transcervical resection of the endometrium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572496     DOI: 10.1097/01.AOG.0000143824.16435.91

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

Review 1.  The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Authors:  Andrew M Kaunitz; Pirjo Inki
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

Review 2.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

Review 3.  Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.

Authors:  Magdalena Bofill Rodriguez; Sofia Dias; Vanessa Jordan; Anne Lethaby; Sarah F Lensen; Michelle R Wise; Jack Wilkinson; Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-05-31

4.  Menorrhagia: a synopsis of management focusing on herbal and nutritional supplements, and chiropractic.

Authors:  Anna B Livdans-Forret; Phyllis J Harvey; Susan M Larkin-Thier
Journal:  J Can Chiropr Assoc       Date:  2007-12

5.  Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding.

Authors:  Robert L Dood; Clarisa R Gracia; Mary D Sammel; Kevin Haynes; Suneeta Senapati; Brian L Strom
Journal:  J Minim Invasive Gynecol       Date:  2014-02-28       Impact factor: 4.137

Review 6.  Abnormal uterine bleeding: a review of patient-based outcome measures.

Authors:  Kristen A Matteson; Lori A Boardman; Malcolm G Munro; Melissa A Clark
Journal:  Fertil Steril       Date:  2008-07-16       Impact factor: 7.329

Review 7.  Surgery versus medical therapy for heavy menstrual bleeding.

Authors:  Jane Marjoribanks; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2016-01-29

8.  Counselling patients with uterine fibroids: a review of the management and complications.

Authors:  Donnette Simms-Stewart; Horace Fletcher
Journal:  Obstet Gynecol Int       Date:  2012-01-09

9.  Progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-06-12

10.  Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report.

Authors:  Xiangjuan Chen; Xueqing Wu; Haiyan Zhu
Journal:  BMC Res Notes       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.